The study on genotypes and drug resistance-mutations of HBV in chronic hepatitis B patients in Yongchuan area

VernacularTitle:永川地区慢性乙型肝炎患者病毒基因分型及耐药性研究
Author: Hongying DAI ; Shiwei WANG ; Tianjin ZHU ; Ke WANG
Publication Type:Journal Article
Keywords: hepatitis B virus; genotype; drug resistance
From: Chongqing Medicine 2013;(36):4395-4396,4399
CountryChina
Language:Chinese
Abstract: Objective To investigate the relationship among HBV genotypes ,nucleoside analogues drug resistance-mutations and the patients with chronic hepatitis B in Yongchuan area .Methods The gene chip was used to detect the nucleoside analogues drug resistance-mutations of 605 cases with chronic hepatitis B ,and the HBV-DNA level was analysised after the antiviral therapy .Re-sults Among 605 cases ,63 .1% genotype were genotype B ,116 cases(19 .17% ) were found to be resistance mutants .The major drug resistance-mutations was genotype B ,49 .14% drug resistance-mutations was Adefovir drug resistance-mutations ,and the re-sistance rate of genotype B with reverse transcriptase 236T mutation was 35 .09% .The resistance rate of genotype B Lamivudine drug resistance-mutations with reverse transcriptase 108M mutation was 34 .29% ,the virus replication between resistance and non-resistant virus were significant difference (P<0 .05) .Conclusion To monitor the hepatitis B patients with HBV resistance gene mutations is beneficial to detect the patients with drug resistance-mutations early ,which is important for selecting reasonable treat-ment methods in clinical practice .